Advertisement

Pediatric Head and Neck Malignancies

  • Michelle GentileEmail author
  • Bree Eaton
Chapter
Part of the Practical Guides in Radiation Oncology book series (PGRO)

Abstract

  • Head and neck malignancies account for approximately 5% of all pediatric tumors.

  • Although relatively rare, pediatric head and neck malignancies are challenging from a treatment-planning standpoint given proximity to critical structures and developing normal tissue.

  • This chapter provides practical contouring guidelines for common pediatric head and neck tumors including malignant tumors such as rhabdomyosarcoma, Ewing sarcoma, salivary gland tumors, and the benign, but locally aggressive, nasopharyngeal angiofibroma.

  • Rhabdomyosarcoma and Ewing sarcoma are covered more broadly in Chaps.  8 and  9.

References

  1. 1.
    Gurney JG, Severson RK, Davis S et al (1995) Incidence of cancer in children in the United States. Sex-, race- and 1-year age-specific rates by histological type. Cancer 75(8):2186–2195CrossRefGoogle Scholar
  2. 2.
    Crist W, Gehan EA, Ragab AH et al (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13(3):610–630CrossRefGoogle Scholar
  3. 3.
    Maurer HM, Gehan EA, Beltangady M et al (1993) The intergroup rhabdomyosarcoma study-II. Cancer 71(5):1904–1922CrossRefGoogle Scholar
  4. 4.
    Raney RB, Anderson JR, Barr FG et al (2001) Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23(4):215–220CrossRefGoogle Scholar
  5. 5.
    Lawrence W, Hays DM, Heyn R et al (1987) Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study. Cancer 60(4):910–915CrossRefGoogle Scholar
  6. 6.
    Merks JH, De Salvo GL, Bergeron C et al (2014) Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. Ann Oncol 25(1):231–236CrossRefGoogle Scholar
  7. 7.
    Pappo AS, Meza JL, Donaldson SS et al (2003) Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. J Clin Oncol 21(4):638–645CrossRefGoogle Scholar
  8. 8.
    Michalski JM, Meza J, Breneman JC et al (2004) Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Int J Radiat Oncol Biol Phys 59(4):1027–1038CrossRefGoogle Scholar
  9. 9.
    Federico SM, Spunt SL, Krasin MJ et al (2013) Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma. Pediatr Blood Cancer 60(7):1128–1134CrossRefGoogle Scholar
  10. 10.
    Regine WF, Fontanesi J, Kumar P et al (1995) Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients. Int J Radiat Oncol Biol Phys 31(3):485–491CrossRefGoogle Scholar
  11. 11.
    Wolden SL, Anderson JR, Crist WM et al (1999) Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 17(11):3468–3475CrossRefGoogle Scholar
  12. 12.
    Raney RB, Meza J, Anderson JR et al (2002) Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS II through IV, 1978-1997. Med Pediatr Oncol 38(1):22–32CrossRefGoogle Scholar
  13. 13.
    Oberlin O, Rey A, Anderson J et al (2001) Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment—results of an international workshop. J Clin Oncol 19(1):197–204CrossRefGoogle Scholar
  14. 14.
    Spaulding AC, Hawkins DS, Donaldson SS et al (2013) The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803. Int J Radiat Oncol Biol Phys 87(3):512–516CrossRefGoogle Scholar
  15. 15.
    Yock T, Schneider R, Friedmann A et al (2005) Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys 63(4):1161–1168CrossRefGoogle Scholar
  16. 16.
    Ladra MM, Edgington SK, Mahajan A et al (2014) A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiother Oncol 113(1):77–83CrossRefGoogle Scholar
  17. 17.
    Marks LB, Yorke ED, Jackson A et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76(3):S10–S19CrossRefGoogle Scholar
  18. 18.
    Raney RB, Asmar L, Newton WA Jr et al (1997) Ewing’s sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol 15(2):574–582CrossRefGoogle Scholar
  19. 19.
    Delattre O, Zucman J, Melot T et al (1994) The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331(5):292–299CrossRefGoogle Scholar
  20. 20.
    Parham DM, Hijazi Y, Steinberg SM et al (1999) Neuroectodermal differentiation in Ewing’s sarcoma family of tumors dose not predict tumor behavior. Hum Pathol 30(8):911–918CrossRefGoogle Scholar
  21. 21.
    Bacci G, Longhi A, Ferrari S et al (2006) Prognostic factors in non-metastatic Ewing’s sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol 45(4):469–475CrossRefGoogle Scholar
  22. 22.
    Esiashvili N, Goodman M, Marcus RB et al (2008) Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol 30(6):425–430CrossRefGoogle Scholar
  23. 23.
    Karski EE, Mclivaine E, Segal MR et al (2015) Identification of discrete prognostic groups in Ewing Sarcoma. Pediatr Blood Cancer 63(1):47–53CrossRefGoogle Scholar
  24. 24.
    Wunder JS, Paulian G, Huvos AG et al (1998) The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am 80(7):1020–1033CrossRefGoogle Scholar
  25. 25.
    Applebaum MA, Goldsby R, Neuhaus J et al (2012) Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement. Pediatr Blood Cancer 59(4):617–620CrossRefGoogle Scholar
  26. 26.
    Paulussen M, Ahrens S, Dunst J et al (2001) Localized Ewing tumor of bone: final results of the cooperative Ewing’s Sarcoma Study CESS 86. J Clin Oncol 19(6):1818–1829CrossRefGoogle Scholar
  27. 27.
    Grevener K, Haveman LM, Ranft A et al (2015) Management and outcome of Ewing sarcoma of the head and neck. Pediatr Blood Cancer 63(4):604–610CrossRefGoogle Scholar
  28. 28.
    Luna MA, Batsakis JG, el-Naggar AK (1991) Salivary gland tumors in children. Ann Otol Rhinol Laryngol 100:869–871CrossRefGoogle Scholar
  29. 29.
    Kupferman ME, de la Garza GO, Santillan AA et al (2010) Outcomes of pediatric patients with malignancies of the major salivary glands. Ann Surg Oncol 17:3301–3307CrossRefGoogle Scholar
  30. 30.
    Terhaard CH, Lubsen H, Rasch CR et al (2005) The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 61:103–111CrossRefGoogle Scholar
  31. 31.
    Chen AM, Garcia J, Lee NY, Bucci MK, Eisele DW (2007) Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 67:988–994CrossRefGoogle Scholar
  32. 32.
    NRG RTOG 1008 (2015) A randomized phase II/phase III study of adjuvant concurrent radiation and chemotherapy versus radiation alone in resected high risk malignant salivary gland tumors. https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1008. Accessed 28 June 2016
  33. 33.
    Gregoire V, Eisbruch A, Hamoir M, Levendag P (2006) Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79:15–20CrossRefGoogle Scholar
  34. 34.
    Radiation Therapy Oncology Group (2013) Consensus atlas for CT-based delineation of nodal regions in the N0 neckGoogle Scholar
  35. 35.
    Ko HC, Gupta V, Mourad WF et al (2014) A contouring guide for head and neck cancers with perineural invasion. Pract Radiat Oncol 4:e247–e258CrossRefGoogle Scholar
  36. 36.
    Allan BJ, Tashiro J, Diaz S, Edens J, Younis R, Thaller SR (2013) Malignant tumors of the parotid gland in children: incidence and outcomes. J Craniofac Surg 24:1660–1664CrossRefGoogle Scholar
  37. 37.
    Batsakis JG (1979) Tumors of the Head and Neck: Clinical and Pathological Considerations, 2nd edn. Williams & Wilkins, Baltimore, MD, pp 296–300Google Scholar
  38. 38.
    Radkowski D, McGill T, Healy GB et al (1996) Angiofibroma: changes in staging and treatment. Arch Otolaryngol Head Neck Surg 122:122–129CrossRefGoogle Scholar
  39. 39.
    Szymańska A, Szymański M, Morshed K et al (2013) Extranasopharyngeal angiofibroma: clinical and radiological presentation. Eur Arch Otorhinlaryngol 270(2):655–660CrossRefGoogle Scholar
  40. 40.
    Bales C, Kotapka M, Loevner LLA et al (2002) Craniofacial resection of advanced juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 128(9):1071–1078CrossRefGoogle Scholar
  41. 41.
    Lee JT, Chen P, Safa A et al (2002) The role of radiation in the treatment of advanced juvenile angiofibroma. Laryngoscope 112:1213–1220CrossRefGoogle Scholar
  42. 42.
    Gupta AC, Murphy DP (1997) Intracranial juvenile nasopharyngeal angiofibroma. Aust N Z Surg 67:477–482CrossRefGoogle Scholar
  43. 43.
    Patil RN, Agarwal AK, Prakash B et al (1982) Clinical records: extra-nasopharyngeal extensions of angiofibroma. J Laryngol Otol 96:1053–1064CrossRefGoogle Scholar
  44. 44.
    Hosseini SM, Borghei P, Borghei SH et al (2005) Angiofibroma: an outcome review of conventional surgical approaches. Eur Arch Otorhinolaryngol 262(10):807–812CrossRefGoogle Scholar
  45. 45.
    Pryor SG, Moore EJ, Kasperbauer JL et al (2005) Endoscopic versus traditional approaches for excision of juvenile nasopharyngeal angiofibroma. Laryngoscope 115:1201–1207CrossRefGoogle Scholar
  46. 46.
    McAfee WJ, Morris CG, Amdur RJ et al (2006) Definitive radiotherapy for juvenile nasopharyngeal angiofibroma. Am J Clin Oncol 29:168–170CrossRefGoogle Scholar
  47. 47.
    Roche PH, Paris J, Régis J et al (2007) Management of invasive juvenile nasopharyngeal angiofibromas: the role of a multimodality approach. Neurosurgery 61(4):768–777CrossRefGoogle Scholar
  48. 48.
    Goepfert H, Cangir A, Lee YY et al (1985) Chemotherapy for aggressive juvenile nasopharyngeal angiofibroma. Arch Otolaryngol 111:285–289CrossRefGoogle Scholar
  49. 49.
    Labra A, Chavolla-Magana R, Lopez-Ugalde A et al (2004) Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases. Otolaryngol Head Neck Surg 130:466–469CrossRefGoogle Scholar
  50. 50.
    Chakraborty S, Ghoshal S, Patil VM et al (2011) Conformal radiotherapy in the treatment of advanced juvenile nasopharyngeal angiofibroma with intracranial extension: an institutional experience. Int J Radiat Oncol Biol Phys 80(5):1398–1404CrossRefGoogle Scholar
  51. 51.
    Khoueir N, Nicolas N, Rohayem Z et al (2014) Exclusive endoscopic resection of juvenile nasopharyngeal angiofibroma: a systematic review of the literature. Otolaryngol Head Neck Surg 150(3):350–358CrossRefGoogle Scholar
  52. 52.
    Leong SC (2013) A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement. Laryngoscope 123(5):1125–1131CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Radiation OncologyNorthwestern UniversityChicagoUSA
  2. 2.Department of Radiation OncologyEmory UniversityAtlantaUSA

Personalised recommendations